A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Desmopressin (Primary)
- Indications Nocturia
- Focus Adverse reactions
- Sponsors Ferring Pharmaceuticals
- 23 May 2016 Status changed from active, no longer recruiting to completed.
- 15 Apr 2015 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 15 Apr 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov record.